Protalix Biotherapeutics Inc. buy marge
Start price
12.04.17
/
50%
€10.35
Target price
26.07.17
€20.00
Performance (%)
-40.29%
End price
26.07.17
€6.18
Summary
This prediction ended on 26.07.17 with a price of €6.18. Massive losses of -40.29% were the result for the BUY prediction by marge. marge has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Protalix Biotherapeutics Inc. | 8.967% | 8.967% | 64.103% | -5.882% |
| iShares Core DAX® | 0,56 % | 0,44 % | 5,87 % | 54,93 % |
| iShares Nasdaq 100 | -0,16 % | 1,62 % | 37,06 % | 90,56 % |
| iShares Nikkei 225® | 1,10 % | 9,61 % | 65,64 % | 80,26 % |
| iShares S&P 500 | 0,01 % | 0,69 % | 25,68 % | 67,61 % |
Comments by marge for this prediction
In the thread Protalix Biotherapeutics Inc. diskutieren
marge stimmt der Buy-Einschätzung von datca zu
marge stimmt am 124.2017 der Buy-Einschätzung von datca mit dem Kursziel 2€ zu.Überschrift: Protalix for the Treatment of Cystic Fibrosis and Fabry Disease
(Vom Mitglied beendet)